Plato Investment Management’s Idexx Laboratories IDXX Stock Holding History

Plato Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.74M	Hold	3,089	–	–	0.12%	183
2025 Q4	$2.1M	Hold	3,089	–	–	0.14%	157
2025 Q3	$1.96M	Hold	3,089	–	–	0.13%	170
2025 Q2	$1.65M	Buy	3,089 +2	+0.1%	+$956	0.12%	179
2025 Q1	$1.31M	Buy	3,087 +835	+37%	+$363K	0.11%	204
2024 Q4	$934K	Buy	2,252 +819	+57%	+$359K	0.07%	262
2024 Q3	$723K	Sell	1,433 -22	-2%	-$10.7K	0.06%	282
2024 Q2	$709K	Sell	1,455 -54	-4%	-$27.1K	0.07%	245
2024 Q1	$815K	Buy	1,509 +1,424	+1,675%	+$778K	0.08%	225
2023 Q4	$47.2K	Buy	+85	New	+$39.9K	0.06%	233

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Plato Investment Management's IDXX Position: Q1 2026 in Review

Plato Investment Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 3,089 shares worth $1.74M. The position accounts for 0.12% of the portfolio, ranked #183.

Plato Investment Management first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.1M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Plato Investment Management held 3,089 shares of Idexx Laboratories worth $1.74M as of Q1 2026.
Plato Investment Management left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.12% of Plato Investment Management's portfolio in Q1 2026, its #183 holding.
Plato Investment Management first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
Plato Investment Management's Idexx Laboratories position peaked at $2.1M in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.